Alzheimer's disease is one of the world’s most prevalent brain disorders, being extremely difficult to treat. Alzheimer's ...

W ith two new treatments for Alzheimer’s disease approved in recent years, there’s growing hope for people at risk of the memory-robbing condition. But tests to detect the condition still lag behind.

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

These phosphorylated tau species are elevated in the serum not only of AD patients, but also in people with ALS, who likely produce it in their muscles, according to the authors’ findings. Serum ...

The scientists concluded that while the two markers perform similarly, they yield complementary information, and sequential ...

The scans are also expensive and not available at all hospitals. More sensitive ways to detect amyloid and tau, another protein related to the disease, are possible by analyzing spinal fluid ...